Concepts (137)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ovarian Neoplasms | 8 | 2024 | 595 | 0.760 |
Why?
|
| Lysophospholipids | 8 | 2024 | 51 | 0.750 |
Why?
|
| Cell Movement | 5 | 2024 | 373 | 0.440 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2024 | 465 | 0.440 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2024 | 170 | 0.310 |
Why?
|
| Glycolysis | 3 | 2018 | 91 | 0.300 |
Why?
|
| Biosensing Techniques | 2 | 2009 | 47 | 0.300 |
Why?
|
| Cell Proliferation | 6 | 2024 | 815 | 0.290 |
Why?
|
| GTP-Binding Protein alpha Subunit, Gi2 | 2 | 2021 | 8 | 0.290 |
Why?
|
| Saccharomyces cerevisiae | 3 | 2009 | 176 | 0.280 |
Why?
|
| Cell Line, Tumor | 9 | 2024 | 1338 | 0.260 |
Why?
|
| GTP-Binding Protein alpha Subunits, G12-G13 | 3 | 2013 | 15 | 0.240 |
Why?
|
| Reactive Oxygen Species | 2 | 2018 | 290 | 0.240 |
Why?
|
| Protein Engineering | 1 | 2005 | 14 | 0.240 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2005 | 65 | 0.230 |
Why?
|
| ErbB Receptors | 2 | 2022 | 100 | 0.220 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2005 | 114 | 0.220 |
Why?
|
| RNA, Long Noncoding | 1 | 2024 | 32 | 0.210 |
Why?
|
| Receptors, Lysophosphatidic Acid | 4 | 2024 | 15 | 0.210 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 3 | 2018 | 59 | 0.190 |
Why?
|
| Endocytosis | 1 | 2022 | 96 | 0.180 |
Why?
|
| Transcription Factors | 1 | 2005 | 523 | 0.180 |
Why?
|
| Antigens, CD | 1 | 2022 | 140 | 0.180 |
Why?
|
| Oxidative Stress | 1 | 2005 | 669 | 0.170 |
Why?
|
| MicroRNAs | 1 | 2024 | 301 | 0.160 |
Why?
|
| N-Myc Proto-Oncogene Protein | 1 | 2019 | 11 | 0.150 |
Why?
|
| Cancer-Associated Fibroblasts | 1 | 2018 | 10 | 0.150 |
Why?
|
| Paracrine Communication | 1 | 2018 | 17 | 0.150 |
Why?
|
| Neuroblastoma | 1 | 2019 | 56 | 0.150 |
Why?
|
| Receptors, Odorant | 2 | 2009 | 7 | 0.150 |
Why?
|
| Membrane Proteins | 1 | 2022 | 485 | 0.150 |
Why?
|
| Polymerase Chain Reaction | 1 | 2019 | 270 | 0.140 |
Why?
|
| Androstane-3,17-diol | 1 | 2017 | 9 | 0.140 |
Why?
|
| src-Family Kinases | 2 | 2016 | 71 | 0.140 |
Why?
|
| Anabolic Agents | 1 | 2017 | 12 | 0.140 |
Why?
|
| Aldo-Keto Reductase Family 1 Member C3 | 1 | 2017 | 21 | 0.140 |
Why?
|
| Receptors, GABA-A | 1 | 2017 | 18 | 0.140 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2017 | 23 | 0.130 |
Why?
|
| Calcium-Binding Proteins | 1 | 2017 | 62 | 0.130 |
Why?
|
| Cation Transport Proteins | 1 | 2017 | 60 | 0.130 |
Why?
|
| Snail Family Transcription Factors | 1 | 2016 | 10 | 0.130 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2016 | 163 | 0.120 |
Why?
|
| Signal Transduction | 4 | 2024 | 1454 | 0.110 |
Why?
|
| Mice, Nude | 3 | 2024 | 332 | 0.110 |
Why?
|
| Rho Guanine Nucleotide Exchange Factors | 1 | 2014 | 4 | 0.110 |
Why?
|
| Cell Surface Extensions | 1 | 2014 | 5 | 0.110 |
Why?
|
| Prostatic Neoplasms | 1 | 2017 | 282 | 0.110 |
Why?
|
| Humans | 14 | 2024 | 28581 | 0.110 |
Why?
|
| Protein Transport | 1 | 2014 | 158 | 0.110 |
Why?
|
| Biomarkers, Tumor | 2 | 2019 | 409 | 0.100 |
Why?
|
| Neoplasms | 1 | 2022 | 857 | 0.100 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2011 | 133 | 0.100 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2018 | 78 | 0.100 |
Why?
|
| Liver Neoplasms | 2 | 2011 | 167 | 0.100 |
Why?
|
| Female | 8 | 2024 | 15471 | 0.090 |
Why?
|
| Boronic Acids | 1 | 2010 | 9 | 0.080 |
Why?
|
| Pyrazines | 1 | 2010 | 24 | 0.080 |
Why?
|
| Proteasome Inhibitors | 1 | 2010 | 26 | 0.080 |
Why?
|
| Protease Inhibitors | 1 | 2010 | 40 | 0.080 |
Why?
|
| Cisplatin | 2 | 2024 | 183 | 0.080 |
Why?
|
| Antineoplastic Agents | 2 | 2017 | 681 | 0.080 |
Why?
|
| Animals | 7 | 2024 | 10580 | 0.080 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2022 | 115 | 0.080 |
Why?
|
| Mice | 4 | 2024 | 4732 | 0.070 |
Why?
|
| Organisms, Genetically Modified | 1 | 2007 | 5 | 0.070 |
Why?
|
| Smell | 1 | 2007 | 13 | 0.070 |
Why?
|
| Heterografts | 2 | 2018 | 66 | 0.070 |
Why?
|
| Phenotype | 2 | 2018 | 682 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 2 | 2017 | 314 | 0.060 |
Why?
|
| Green Fluorescent Proteins | 1 | 2005 | 101 | 0.060 |
Why?
|
| Species Specificity | 1 | 2005 | 193 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 611 | 0.050 |
Why?
|
| Protein Binding | 2 | 2016 | 664 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2024 | 274 | 0.050 |
Why?
|
| Cell Adhesion | 2 | 2014 | 139 | 0.050 |
Why?
|
| Integrins | 1 | 2022 | 29 | 0.050 |
Why?
|
| Transcriptome | 1 | 2021 | 214 | 0.040 |
Why?
|
| Formaldehyde | 1 | 2019 | 11 | 0.040 |
Why?
|
| Paraffin Embedding | 1 | 2019 | 14 | 0.040 |
Why?
|
| Gene Amplification | 1 | 2019 | 22 | 0.040 |
Why?
|
| Ascitic Fluid | 1 | 2018 | 11 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2019 | 75 | 0.040 |
Why?
|
| Culture Media, Conditioned | 1 | 2018 | 31 | 0.040 |
Why?
|
| Hexokinase | 1 | 2018 | 16 | 0.040 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2018 | 21 | 0.040 |
Why?
|
| Cell Hypoxia | 1 | 2018 | 35 | 0.030 |
Why?
|
| NADPH Oxidases | 1 | 2018 | 69 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 465 | 0.030 |
Why?
|
| Pyruvate Dehydrogenase Complex | 1 | 2017 | 19 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2019 | 524 | 0.030 |
Why?
|
| Oxidative Phosphorylation | 1 | 2017 | 29 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2017 | 64 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2016 | 12 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2016 | 110 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 134 | 0.030 |
Why?
|
| Calcium | 1 | 2017 | 243 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2018 | 419 | 0.030 |
Why?
|
| Disease Progression | 1 | 2017 | 475 | 0.030 |
Why?
|
| Focal Adhesions | 1 | 2014 | 15 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2014 | 190 | 0.030 |
Why?
|
| Models, Biological | 1 | 2016 | 468 | 0.030 |
Why?
|
| Apoptosis | 1 | 2017 | 777 | 0.030 |
Why?
|
| RNA Interference | 1 | 2013 | 137 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2014 | 515 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2013 | 124 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 328 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 1494 | 0.020 |
Why?
|
| Antigens, Neoplasm | 1 | 2011 | 56 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2011 | 67 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2010 | 43 | 0.020 |
Why?
|
| Bortezomib | 1 | 2010 | 22 | 0.020 |
Why?
|
| Recurrence | 1 | 2011 | 325 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2011 | 117 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 2011 | 148 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2010 | 80 | 0.020 |
Why?
|
| Prognosis | 1 | 2011 | 807 | 0.020 |
Why?
|
| Cell Line | 1 | 2010 | 698 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2010 | 667 | 0.020 |
Why?
|
| Adenylyl Cyclases | 1 | 2007 | 14 | 0.020 |
Why?
|
| Odorants | 1 | 2007 | 10 | 0.020 |
Why?
|
| Genetic Engineering | 1 | 2007 | 24 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2007 | 87 | 0.020 |
Why?
|
| Pancreatic Neoplasms | 1 | 2013 | 546 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2007 | 208 | 0.020 |
Why?
|
| Mammals | 1 | 2007 | 48 | 0.020 |
Why?
|
| Transfection | 1 | 2007 | 319 | 0.020 |
Why?
|
| Rats | 1 | 2009 | 1587 | 0.020 |
Why?
|
| Suramin | 1 | 2005 | 1 | 0.010 |
Why?
|
| Guanosine Diphosphate | 1 | 2005 | 18 | 0.010 |
Why?
|
| Pertussis Toxin | 1 | 2005 | 7 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 2005 | 46 | 0.010 |
Why?
|
| Guanosine Triphosphate | 1 | 2005 | 29 | 0.010 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2005 | 33 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2007 | 1056 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2005 | 267 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2005 | 120 | 0.010 |
Why?
|
| Male | 1 | 2017 | 13771 | 0.010 |
Why?
|